Clinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients

Por Zhu, Yu, Qian, Si-Xuan
Publicado em 2014

Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients

Por Qiao, Chun, Sun, Chao, Ouyang, Yuan, Wang, Ju-Juan, Qian, Si-Xuan, Li, Jian-Yong, Zhang, Su-Jiang
Publicado em 2014

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group

Por Guo, Mei, Chao, Nelson J., Li, Jian-Yong, Rizzieri, David A., Sun, Qi-Yun, Mohrbacher, Ann, Krakow, Elizabeth F., Sun, Wan-Jun, Shen, Xu-Liang, Zhan, Xin-Rong, Wu, De-Pei, Liu, Li, Wang, Juan, Zhou, Min, Yang, Lin-Hua, Bao, Yang-Yi, Dong, Zheng, Cai, Bo, Hu, Kai-Xun, Yu, Chang-Lin, Qiao, Jian-Hui, Zuo, Hong-Li, Huang, Ya-Jing, Sung, Anthony D., Qiao, Jun-Xiao, Liu, Zhi-Qing, Liu, Tie-Qiang, Yao, Bo, Zhao, Hong-Xia, Qian, Si-Xuan, Liu, Wei-Wei, Forés, Rafael, Duarte, Rafael F., Ai, Hui-Sheng
Publicado no JAMA Oncol (2017)